NCT01918969 (ANOPEC2) is a clinical trial in Aortic Aneurysm, sponsored by Hopital Jean Minjoz.

Who is sponsoring NCT01918969?

NCT01918969 is sponsored by Hopital Jean Minjoz.

What condition does NCT01918969 study?

NCT01918969 studies Aortic Aneurysm.

Is NCT01918969 still recruiting?

NCT01918969 is currently status unknown. Last updated 7 August 2013.

Last reviewed 2013-08-07 · How we verify

NCT01918969: ANOPEC2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Determination of Reference Values of Circulating Endothelial Progenitor Cells CD34+144+CD14- and CD34+VEGF-R2+CD14- in a Blood Donnor Population

Status unknown Last updated 7 August 2013

What this trial tests

trial in Aortic Aneurysm in 120 participants. Status unknown.

Timeline

1 October 2013

Primary endpoint
1 January 2014

1 March 2014

Quick facts

Lead sponsor	Hopital Jean Minjoz
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	120
Start date	1 October 2013
Primary completion	1 January 2014
Estimated completion	1 March 2014
Sites	1 location across France

Conditions studied

Aortic Aneurysm — all drugs for Aortic Aneurysm →

Sponsor

Hopital Jean Minjoz

Who can join

Adults 18 to 65, any sex, with Aortic Aneurysm. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Concentration of circulating endothelial progenitor cells CD34+144+CD14- and CD34+VEGF-R2+CD14-
Time frame: 3 months

Sponsor's own description

Circulating endothelial progenitor cells CD34+144+CD14- et CD34+VEGF-R2+CD14- have been shown to be inversely correlated to aortic aneurysm size. However reference values have not yet been determined. This study is aimed to determine reference values of CD34+144+CD14- et CD34+VEGF-R2+CD14- in healthy men and women blood donors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Aortic Aneurysm

Currently open trials in the same condition.

NCT07438327 — AI-CARE: Artificial Intelligence for Cardiovascular Analysis and Risk Evaluation · recruiting
NCT06998498 — Prehabilitation for Aortic Aneurysm Surgery: Proof-of-concept Trial · NA · recruiting
NCT06549348 — Radiation Free Study · NA · recruiting
NCT06834607 — Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Complex Aortic Aneurysms · NA · recruiting
NCT06762561 — Prophylactic Mesh Reinforcement After Open Aortic Aneurysm Repair · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01918969 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hopital Jean Minjoz
Last refreshed: 7 August 2013

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01918969.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing